Marshall Wace North America’s Cardinal Health CAH Stock Holding History

Marshall Wace North America’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$223K	Buy	+4,517	New	+$245K	﹤0.01%	1300
2021 Q1	–	Sell	-486,334	Closed	-$26M	–	1525
2020 Q4	$26M	Buy	486,334 +334,737	+221%	+$17.4M	0.12%	205
2020 Q3	$7.12M	Sell	151,597 -3,912	-3%	-$201K	0.05%	332
2020 Q2	$8.12M	Buy	155,509 +78,436	+102%	+$4.04M	0.05%	292
2020 Q1	$3.69M	Buy	+77,073	New	+$4M	0.03%	371
2019 Q1	–	Sell	-77,078	Closed	-$3.44M	–	1575
2018 Q4	$3.44M	Buy	+77,078	New	+$4.02M	0.03%	323
2018 Q1	–	Sell	-3,418	Closed	-$209K	–	1446
2017 Q4	$209K	Buy	+3,418	New	+$211K	﹤0.01%	1282
2013 Q4	$3.08M	Buy	+46,079	New	+$2.82M	0.07%	235

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace North America's CAH Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Cardinal Health (CAH) in Q3 2021: 4,517 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1300 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in CAH as recently as Q4 2020.

Marshall Wace North America first reported a position in CAH in Q4 2013 and has held it in 8 quarters since. The position peaked at $26M in Q4 2020. 750 funds tracked by Wall St. Rank hold CAH as of Q3 2021.

Marshall Wace North America held 4,517 shares of Cardinal Health worth $223K as of Q3 2021.
Cardinal Health was a new Marshall Wace North America position in Q3 2021.
Cardinal Health made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1300 holding.
Marshall Wace North America first reported a position in Cardinal Health in Q4 2013 and has held it in 8 quarters since.
Marshall Wace North America's Cardinal Health position peaked at $26M in Q4 2020.
750 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.